Yau C - Search Results

1

Hormone Receptor Positive HER2-negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple Negative Breast Cancers.

Rios-Hoyo A, Xiong K, Dai J, Yau C, Marczyk M, Garcia-Milian R, Wolf DM, Huppert LA, Nanda R, Hirst GL, Cobain EF, van 't Veer LJ, Esserman LJ, Pusztai L. Rios-Hoyo A, et al. Among authors: yau c. Clin Cancer Res. 2024 Nov 19. doi: 10.1158/1078-0432.CCR-24-1553. Online ahead of print. Clin Cancer Res. 2024. PMID: 39561272

2

Post-traumatic stress disorder and symptoms in paediatric cancer survivors and their family nucleus: systematic review, meta-analysis and meta-regression.

Low CE, Tan SYP, Loh A, Yu J, Ong JZE, Loh CYL, Yau CE, Lee ARYB, Ho CSH. Low CE, et al. Among authors: yau ce. BJPsych Open. 2024 Nov 11;10(6):e207. doi: 10.1192/bjo.2024.805. BJPsych Open. 2024. PMID: 39523667 Free article. Review.

3

Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancer.

Campbell MJ, Wolf DM, Yau C, Brown-Swigart L, Wulfkuhle J, Gallagher IR, Zhu Z, Bolen J, Vandenberg S, Hoyt C, Mori H, Borowsky A, Sit L, Perlmutter J, Asare SM; I-SPY2 Investigators; Nanda R, Liu MC, Yee D, DeMichele AM, Hylton NM, Pusztai L, Berry DA, Hirst GL, Petricoin EF, Veer LV, Esserman L. Campbell MJ, et al. Among authors: yau c. Cell Rep Med. 2024 Nov 3:101799. doi: 10.1016/j.xcrm.2024.101799. Online ahead of print. Cell Rep Med. 2024. PMID: 39510069 Free article.

4

Pathologic complete response (pCR) rates for patients with HR+/HER2- high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trial.

Huppert LA, Wolf D, Yau C, Brown-Swigart L, Hirst GL, Isaacs C, Pusztai L, Pohlmann PR, DeMichele A, Shatsky R, Yee D, Thomas A, Nanda R, Perlmutter J, Heditsian D, Hylton N, Symmans F, Veer LJV', Esserman L, Rugo HS. Huppert LA, et al. Among authors: yau c. Ann Oncol. 2024 Oct 28:S0923-7534(24)04070-5. doi: 10.1016/j.annonc.2024.10.018. Online ahead of print. Ann Oncol. 2024. PMID: 39477071

5

Effectiveness of immune checkpoint inhibitors and other treatment modalities in patients with advanced mucosal melanomas: a systematic review and individual patient data meta-analysis.

Teo AYT, Yau CE, Low CE, Pereira JV, Ng JYX, Soong TK, Lo JYT, Yang VS. Teo AYT, et al. Among authors: yau ce. EClinicalMedicine. 2024 Oct 4;77:102870. doi: 10.1016/j.eclinm.2024.102870. eCollection 2024 Nov. EClinicalMedicine. 2024. PMID: 39416390 Free PMC article.

6

A cross-sectional study on advance care planning documentation attitudes during national advance care planning week in a South-East Asian country.

Low CE, Rana S, Yau CE, Tan SYP, Ng JN, Ru CM, Soh K, Chan N, Ng RHL, Lim MJR. Low CE, et al. Among authors: yau ce. BMC Palliat Care. 2024 Oct 17;23(1):244. doi: 10.1186/s12904-024-01505-4. BMC Palliat Care. 2024. PMID: 39415174 Free PMC article.

7

Using Deauville Scoring to Guide Consolidative Radiotherapy in Diffuse Large B-Cell Lymphoma.

Yau CE, Low CE, Ong WS, Khoo LP, Hoe JTM, Tan YH, Chang EWY, Yang VS, Poon EYL, Chan JY, Sin IH, Yeoh KW, Somasundaram N, Harunal Rashid MFB, Tao M, Lim ST, Chiang J. Yau CE, et al. Cancers (Basel). 2024 Sep 27;16(19):3311. doi: 10.3390/cancers16193311. Cancers (Basel). 2024. PMID: 39409931 Free PMC article.

8

Validation study of risk-reduction activities after personalized breast cancer education tool in the WISDOM study.

Wang T, Che M, Huilgol YS, Keane H, Goodman D, Soonavala R, Ozanne E, Shieh Y, Belkora JK, Fiscalini AS; Athena Breast Health Network Investigators and Advocate Partners; Esserman LJ. Wang T, et al. NPJ Breast Cancer. 2024 Oct 14;10(1):90. doi: 10.1038/s41523-024-00681-z. NPJ Breast Cancer. 2024. PMID: 39397069 Free PMC article.

9

A circularly permuted CasRx platform for efficient, site-specific RNA editing.

Wang Y, Liu KI, Liu MM, Ooi KH, Nguyen TA, Chee JE, Teo SXD, He S, Tay JWD, Teo SY, Liew KS, Ge XY, Ng ZJ, Avagyan H, Liu H, Yi Z, Chang K, Kok EPL, Chen R, Yau CE, Koh JW, Wan Y, Tan MH. Wang Y, et al. Among authors: yau ce. Nat Biotechnol. 2024 Oct 9. doi: 10.1038/s41587-024-02430-w. Online ahead of print. Nat Biotechnol. 2024. PMID: 39385008

10

Assessing the accuracy and consistency of generative pretrained transformers in assigning Eastern Cooperative Oncology Group performance status.

Yau CE, Xie Q, Ho RYJ, Yau CY, Guan E, Lee DYX, Zhou X, Sng GGR, Tung JYM, Ho AFW, Tan RSYC, Lim DYZ. Yau CE, et al. Among authors: yau cy. Ann Acad Med Singap. 2024 Sep 13;53(9):578-581. doi: 10.47102/annals-acadmedsg.202414. Ann Acad Med Singap. 2024. PMID: 39373376 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

588 results

Search Page

Filters